Related references
Note: Only part of the references are listed.Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
Hagop M. Kantarjian et al.
BLOOD (2012)
Fyn is not essential for Bcr-Abl-induced leukemogenesis in mouse bone marrow transplantation models
Noriko Doki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
Nina Fenouille et al.
CANCER RESEARCH (2010)
The involvement of Fyn kinase in resumption of the first meiotic division in mouse oocytes
Mattan Levi et al.
CELL CYCLE (2010)
The role of Fyn kinase in the release from metaphase in mammalian oocytes
M. Levi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer
Anne-Marie C. Dingemans et al.
MOLECULAR CANCER (2010)
Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex
Kazuhiko Namekata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fyn kinase is involved in cleavage furrow ingression during meiosis and mitosis
Mattan Levi et al.
REPRODUCTION (2010)
Functions of Fyn kinase in the completion of meiosis in mouse oocytes
Lynda K. McGinnis et al.
DEVELOPMENTAL BIOLOGY (2009)
Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells
Yin Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors
Sebastien Grosso et al.
MOLECULAR CANCER THERAPEUTICS (2009)
BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia
Kechen Ban et al.
BLOOD (2008)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Dissecting the senescence-like program in tumor cells activated by Ras signaling
Teeru Bihani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Fusion tyrosine kinases: a result and cause of genomic instability
E. T. P. Penserga et al.
ONCOGENE (2007)
Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity
Malcolm A. Meyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene expression changes associated with progression and response in chronic myeloid leukemia
JP Radich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions
CB Coyne et al.
CELL (2006)
Adhesion signaling by a novel mitotic substrate of src kinases
AS Bhatt et al.
ONCOGENE (2005)
Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death
BAA Weaver et al.
CANCER CELL (2005)
Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability
M Giehl et al.
LEUKEMIA (2005)
BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia
SA Doggrell
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia
YG Hu et al.
NATURE GENETICS (2004)
Complexes of γ-tubulin with nonreceptor protein tyrosine kinases Src and Fyn in differentiating P19 embryonal carcinoma cells
V Kukharskyy et al.
EXPERIMENTAL CELL RESEARCH (2004)
Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation
EH Palacios et al.
ONCOGENE (2004)
The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation
R Zamoyska et al.
IMMUNOLOGICAL REVIEWS (2003)
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis
MB Wilson et al.
ONCOGENE (2002)
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells
A Klejman et al.
EMBO JOURNAL (2002)
Tr-kit-induced resumption of the cell cycle in mouse eggs requires activation of a Src-like kinase
C Sette et al.
EMBO JOURNAL (2002)
BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90
ME Gorre et al.
BLOOD (2002)
Chronic myelogenous leukemia: mechanisms underlying disease progression
AS Shet et al.
LEUKEMIA (2002)
Oncogenic tyrosine kinases and the DNA-damage response
T Skorski
NATURE REVIEWS CANCER (2002)
Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by Notch-1
LT Lam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck
JM Lionberger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
